The utility of fibrin/fibrinogen degradation products in superficial bladder cancer

Urologic Clinics of North America

Volumn 27, Issue 1, 2000, Pages 39-46

  Tsihlias, John ^a   Grossman, H Barton ^a,b  

^a Department of Urology ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN;

BLADDER CANCER; CANCER GRADING; CANCER STAGING; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN URINE LEVEL; REVIEW; URINE CYTOLOGY;

EID: 0033972460     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70232-9     Document Type: Article

References (23)

1. E.A. Alsabti Prognostic value of urinary fibrinogen degradation products in bladder carcinoma Eur Surg Res 11 1979 185
2. L.F. Brown B. Berse R.W. Jackman Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas Am J Pathol 143 1993 1255
3. M.E. Chen P. Troncoso D.A. Johnston Optimization of prostate biopsy strategy using computer based analysis J Urol 158 1997 2168
4. M.J. Droller Bladder cancer: State-of-the-art care CA Cancer J Clin 48 1998 269
5. R. Ewing G.M. Tate J.W. Hetherington Urinary fibrin/fibrinogen degradation products in transitional cell carcinoma of the bladder Br J Urol 59 1987 53
6. L. Hemmingsen F. Rasmussen P. Skaarup Urinary protein profiles in patients with urothelial bladder tumours Br J Urol 53 1981 324
7. R.P. Huben Tumor markers in bladder cancer Urology 23 1984 10
8. S. Jayachandran M.M. Unni Mooppan S.H. Wax The value of urinary fibrin/fibrinogen degradation products as tumor markers in urothelial carcinoma J Urol 132 1984 21
9. B. Johnston A. Morales L. Emerson Rapid detection of bladder cancer: A comparative study of point of care tests J Urol 158 1997 2098
10. S.H. Landis T. Murray S. Bolden Cancer statistics, 1999 CA Cancer J Clin 49 1999 8
11. J.A. Martinez-Pineiro C. Pertusa E. Maganto Urinary fibrinogen degradation products (FDP) in bladder cancer Eur Urol 4 1978 348
12. R.P. McCabe D.L. Lamm M.V. Haspel A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products Cancer Res 44 1984 5886
13. C. Merskey G.J. Kleiner A.J. Johnson Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment Blood 28 1966 1
14. K. Misra J.S. Chowhan R.L. Gupta Diagnostic role of urine cytology and fibrinogen degradation products in carcinoma of bladder Indian J Cancer 22 1985 145
15. T. O'Brien D. Cranston S. Fuggle Different angiogenic pathways characterize superficial and invasive bladder cancer Cancer Res 55 1995 510
16. S. Ramakumar J. Bhuiyan J.A. Besse Comparison of screening methods in detection of bladder cancer J Urol 161 1999 388
17. B.S. Schmetter K.K. Habicht D.L. Lamm A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer J Urol 158 1997 801
18. D.R. Siemens B. Johnston L. Emerson A comparative analysis of rapid urine testing for the diagnosis of transitional cell carcinoma (TCC) of the upper tracts J Urol 157 suppl 1997 327
19. T. Tanahashi Y. Matsumura H. Ohmori A correlative study on urinary cytology and FDP with cystoscopy and pathology in the urinary bladder cancers Acta Med Okayama 32 1978 139
20. Z. Wajsman C.E. Merrin T.M. Chu Evaluation of biological markers in bladder cancer J Urol 114 1975 879
21. Z. Wajsman P.D. Williams J. Greco Further study of fibrinogen degradation products in bladder cancer detection Urology 12 1978 659
22. K. Worowski R. Farbiszewski Studies on the proteolytic enzyme inhibitors in malignant neoplastic diseases Polish Medical Journal 11 1972 502
23. H. Yu Y. Yanagisawa M.A. Forbes Alpha-1-microglobulin: An indicator protein for renal tubular function J Clin Pathol 36 1983 253